Hepatitis B and C viruses in the development of hepatocellular carcinoma.
Yu
M W
MW
Institute of Epidemiology, College of Public Health, National Taiwan University, Taipei.
Chen
C J
CJ
D000328:Adult; D000348:Aflatoxins / Q000009:adverse effects; D000368:Aged; D000428:Alcohol Drinking / Q000009:adverse effects; D000818:Animals; D006528:Carcinoma, Hepatocellular / Q000453:epidemiology / Q000209:etiology* / Q000662:veterinary / Q000821:virology; D002471:Cell Transformation, Neoplastic; D002472:Cell Transformation, Viral; D002648:Child; D003043:Cocarcinogenesis; D004195:Disease Models, Animal; D005260:Female; D016174:Hepacivirus / Q000472:pathogenicity*; D006509:Hepatitis B / Q000150:complications* / Q000453:epidemiology / Q000662:veterinary; D006515:Hepatitis B virus / Q000472:pathogenicity*; D006526:Hepatitis C / Q000150:complications* / Q000453:epidemiology; D003699:Hepatitis D / Q000150:complications; D006801:Humans; D015994:Incidence; D008103:Liver Cirrhosis / Q000209:etiology; D008113:Liver Neoplasms / Q000453:epidemiology / Q000209:etiology* / Q000662:veterinary / Q000821:virology; D008297:Male; D008875:Middle Aged; D008954:Models, Biological; D009857:Oncogenes; D015995:Prevalence; D012307:Risk Factors; D012907:Smoking / Q000009:adverse effects; D016662:Virus Integration
D000348:Aflatoxins